Literature DB >> 2697183

Human leukocyte antigen (HLA) frequency among patients with nasopharyngeal carcinoma in Taiwan.

S B Wu1, S J Hwang, A S Chang, T Hsieh, M M Hsu, R P Hsieh, C J Chen.   

Abstract

In order to assess the association between human leukocyte antigens (HLA) and nasopharyngeal carcinoma (NPC), a total of 10 familial and 10 sporadic NPC patients and 171 unrelated healthy controls were studied. HLA typing was performed using commercial trays which defined 30 specificities of HLA-A, B and C loci and 10 specificities of HLA-D locus according to the method of Tiwari and Terasaki. HLA-A2, B16 and DR1 were found to be higher among patients with NPC than unrelated healthy controls with an odds ratio (OR) and a 95% confidence interval of 5.91 (2.1-16.6), 6.00 (2.0-18.0) and 6.89 (1.3-37.5), respectively. Further analysis showed that A2(+) B16(+) haplotype was significantly associated with a much higher risk of NPC (OR = 15.5) as compared with A2(-) B16(-) haplotype. No difference in frequency distributions of HLA-A, B, C and D antigens was observed between familial and sporadic NPC patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2697183

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  HLA association with nasopharyngeal carcinoma in southern Tunisia.

Authors:  Hafedh Makni; Jamel Daoud; Hanène Ben Salah; Nedia Mahfoudh; Olfa Haddar; Héla Karray; Tahya Boudawara; Abdelmonême Ghorbel; Abdelmajid Khabir; Mounir Frikha
Journal:  Mol Biol Rep       Date:  2009-08-28       Impact factor: 2.316

2.  Gender-specific associations between MICA-STR and nasopharyngeal carcinoma in a southern Chinese Han population.

Authors:  Wei Tian; Xiao-Min Zeng; Li-Xin Li; He-Kun Jin; Qi-Zhi Luo; Fan Wang; Shi-Shi Guo; Ya Cao
Journal:  Immunogenetics       Date:  2006-03-18       Impact factor: 2.846

3.  Haplotype-dependent HLA susceptibility to nasopharyngeal carcinoma in a Southern Chinese population.

Authors:  M Tang; Y Zeng; A Poisson; D Marti; L Guan; Y Zheng; H Deng; J Liao; X Guo; S Sun; G Nelson; G de Thé; C A Winkler; S J O'Brien; M Carrington; X Gao
Journal:  Genes Immun       Date:  2010-01-14       Impact factor: 2.676

4.  Cancer patterns in nasopharyngeal carcinoma multiplex families in Taiwan.

Authors:  Kelly J Yu; Wan-Lun Hsu; Chun-Ju Chiang; Yu-Juen Cheng; Ruth M Pfeiffer; Scott R Diehl; Alisa M Goldstein; Patti E Gravitt; Chien-Jen Chen; Allan Hildesheim
Journal:  Int J Cancer       Date:  2009-04-01       Impact factor: 7.396

5.  Genetic factors leading to chronic Epstein-Barr virus infection and nasopharyngeal carcinoma in South East China: study design, methods and feasibility.

Authors:  Xiu Chan Guo; Kevin Scott; Yan Liu; Michael Dean; Victor David; George W Nelson; Randall C Johnson; Holli H Dilks; James Lautenberger; Bailey Kessing; Janice Martenson; Li Guan; Shan Sun; Hong Deng; Yuming Zheng; Guy de The; Jian Liao; Yi Zeng; Stephen J O'Brien; Cheryl A Winkler
Journal:  Hum Genomics       Date:  2006-06       Impact factor: 4.639

6.  Further evidence for an HLA-related recessive mutation in nasopharyngeal carcinoma among the Chinese.

Authors:  S P Hu; N E Day; D R Li; R N Luben; K L Cai; T Ou-Yang; B Li; X Z Lu; B A J Ponder
Journal:  Br J Cancer       Date:  2005-03-14       Impact factor: 7.640

Review 7.  The interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma.

Authors:  Maria Li Lung; Arthur Kwok Leung Cheung; Josephine Mun Yee Ko; Hong Lok Lung; Yue Cheng; Wei Dai
Journal:  Chin J Cancer       Date:  2014-11

8.  Evaluation and integration of genetic signature for prediction risk of nasopharyngeal carcinoma in Southern China.

Authors:  Xiuchan Guo; Cheryl A Winkler; Ji Li; Li Guan; Minzhong Tang; Jian Liao; Hong Deng; Guy de Thé; Yi Zeng; Stephen J O'Brien
Journal:  Biomed Res Int       Date:  2014-08-10       Impact factor: 3.411

Review 9.  HLA associations with nasopharyngeal carcinoma.

Authors:  Xin Li; Ross Fasano; Ena Wang; Kai-Tai Yao; Francesco M Marincola
Journal:  Curr Mol Med       Date:  2009-08       Impact factor: 2.222

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.